Conversely, CD8+ T cells are primary effectors of anti-CMV immunity, as evidenced by the inflation of CMV-specific CD8+ memory T cells in response to primary infection and their role in controlling secondary lytic infection [39,40]. This evidence concerns the gene CD8A and infection.